Paige GI Suite
Gastrointestinal Tract Conditions
Key Facts
About Paige
Paige is a pioneering computational pathology company leveraging large-scale foundation models to transform cancer diagnosis and research. The company has achieved significant regulatory milestones, including the first FDA approval for an AI-based pathology product for prostate cancer detection, and offers a suite of AI applications for prostate, breast, gastrointestinal, and pan-cancer analysis. Its business model combines the sale of its diagnostic software to clinical labs with a technology licensing and services arm for biopharma and research institutions. Positioned at the intersection of AI and oncology, Paige aims to address critical bottlenecks in pathology workflows and unlock new insights from tissue-based data.
View full company profile